Journal article · 2025 · Open access
Treatment Strategies in Managing Negative Symptoms in Schizophrenia
European Psychiatry, 68(S1), S1123 · Published 1 April 2025 · DOI 10.1192/j.eurpsy.2025.2271
In brief
“Treatment Strategies in Managing Negative Symptoms in Schizophrenia” is a 2025 journal article by S. Y. Teoh, published in European Psychiatry. OpenAlex counts 0 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at European Psychiatry.
- Citations
- 0
- Authors
- 1
Abstract
Introduction Negative symptoms pose a significant challenge for the treatment and management of schizophrenia. They refer to the loss or diminishment of normal emotional and behavioural functions, which profoundly impact one’s quality of life and socio-occupational outcomes. They are often persistent and difficult to treat. Objectives To explore and assess different treatment strategies for addressing negative symptoms of schizophrenia, including pharmacological, psychosocial, and non-invasive neurostimulation interventions. The goal is to provide an overview of current evidence and recommendations for enhancing the quality of life and functional outcomes in individuals with schizophrenia. Methods We conducted a review of the extant literature to determine treatment strategies for negative symptoms in schizophrenia. We incorporated findings from randomised controlled studies, meta-analyses and systematic reviews. Results We have identified several treatment strategies for negative symptoms in schizophrenia. The literature indicates that second generation antipsychotics such as Cariprazine and Amisulpride are associated with better functional outcomes with lower cognitive impairment. Adding on an anti-depressant, particularly to first-generation antipsychotics, has demonstrated positive effects. Psychosocial interventions including Cognitive Remediation (CR), Social Skills Training (SST) and exercise programs also alleviate negative symptoms. Additionally, non-invasive neurostimulation intervention such as rTMS applied to the left dorsolateral prefrontal cortex (DLPFC) has shown encouraging results in reducing negative symptoms. Conclusions The findings highlight the important of comprehensive and holistic treatment approach integrating both pharmacotherapy and non-pharmacotherapy strategies to address the heterogeneity of negative symptoms. There is a need for further research into personalised treatments that address individual symptom profiles. Disclosure of Interest None Declared
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Teoh, S. Y. (2025). Treatment Strategies in Managing Negative Symptoms in Schizophrenia. European Psychiatry, 68(S1), S1123. https://doi.org/10.1192/j.eurpsy.2025.2271
MLA 9
Teoh, S. Y. “Treatment Strategies in Managing Negative Symptoms in Schizophrenia.” European Psychiatry, vol. 68, no. S1, 2025, p. S1123. https://doi.org/10.1192/j.eurpsy.2025.2271.
Chicago
Teoh, S. Y. 2025. “Treatment Strategies in Managing Negative Symptoms in Schizophrenia.” European Psychiatry 68 (S1): S1123. https://doi.org/10.1192/j.eurpsy.2025.2271.
Harvard
Teoh, S. Y. (2025) ‘Treatment Strategies in Managing Negative Symptoms in Schizophrenia’, European Psychiatry, 68(S1), p. S1123. doi:10.1192/j.eurpsy.2025.2271.
IEEE
S. Y. Teoh, “Treatment Strategies in Managing Negative Symptoms in Schizophrenia,” European Psychiatry, vol. 68, no. S1, p. S1123, 2025, doi: 10.1192/j.eurpsy.2025.2271.
BibTeX
@article{teoh2025treatment,
title = {{Treatment Strategies in Managing Negative Symptoms in Schizophrenia}},
author = {Teoh, S. Y.},
journal = {European Psychiatry},
year = {2025},
volume = {68},
number = {S1},
pages = {S1123},
doi = {10.1192/j.eurpsy.2025.2271},
url = {https://doi.org/10.1192/j.eurpsy.2025.2271}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- schizophrenia
- negative symptoms
- treatment options
- atypical antipsychotics
- cariprazine
- amisulpride
- antidepressant augmentation
- cognitive remediation
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Teoh, S. Y. (2025). Treatment Strategies in Managing Negative Symptoms in Schizophrenia. European Psychiatry, 68(S1), S1123. https://doi.org/10.1192/j.eurpsy.2025.2271
How many times has this paper been cited?
0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at European Psychiatry: sign in and open the PDF from this page.
Who wrote this paper?
S. Y. Teoh.
What is the DOI of this paper?
10.1192/j.eurpsy.2025.2271, permanently at https://doi.org/10.1192/j.eurpsy.2025.2271. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.